Sindelfingen, Germany

Mariola Fotin-Mleczek

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 2.8

ph-index = 17

Forward Citations = 573(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Mariola Fotin-Mleczek in RNA Therapeutics**

Introduction

Mariola Fotin-Mleczek, based in Sindelfingen, Germany, stands out as an accomplished inventor in the field of biotechnology. With a remarkable portfolio of 25 patents, she has significantly contributed to the development of RNA-based therapies and vaccine technologies. Her ground-breaking work addresses crucial medical needs, especially in the fields of oncology and infectious diseases.

Latest Patents

Among her latest inventions, one notable patent is centered around "RNA encoding a therapeutic protein." This invention focuses on RNA that can be utilized as a medicament, providing a foundation for innovative treatments through improved gene therapy methods. This patent highlights compositions and kits containing this novel RNA, which aims to enhance the expression of the encoded therapeutic protein.

Another significant patent is the "Combination of vaccination and OX40 agonists." This patent introduces a combination that includes an RNA vaccine with an OX40 agonist, designed to create a robust therapeutic approach for preventing or treating tumor or cancer diseases, as well as infectious diseases. The invention encompasses the pharmaceutical composition and a kit that combines these elements for enhanced medical use.

Career Highlights

Mariola Fotin-Mleczek has worked with prominent biotechnology companies, including CureVac AG and CureVac SE, where she has made significant strides in RNA technology. Her expertise in developing novel therapeutics is evident through her extensive patent portfolio, which showcases her dedication to advancing medical science.

Collaborations

Throughout her career, Mariola has collaborated with noteworthy professionals in the field, including Karl-Josef Kallen and Jochen Probst. These partnerships have contributed to the successful development of her innovative patents and have helped in elevating the standards of research and development in RNA therapeutics.

Conclusion

In conclusion, Mariola Fotin-Mleczek's contributions to the field of RNA therapeutics underscore her role as a leading inventor in biomedicine. With her innovative patents that combine advanced RNA technology with therapeutic applications, she continues to pave the way for future advancements in treating challenging diseases. Her work inspires many in the scientific community and holds promise for improved health outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…